{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T11:58:12Z","timestamp":1770292692989,"version":"3.49.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T00:00:00Z","timestamp":1304985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s10067-011-1771-9","type":"journal-article","created":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T06:42:51Z","timestamp":1304923371000},"page":"1535-1541","source":"Crossref","is-referenced-by-count":31,"title":["Interferon-\u03b3 release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea"],"prefix":"10.1007","volume":"30","author":[{"given":"Boksoon","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Yun","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeongman","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong Kyong","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoon-Suk","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Mi","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Suk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won-Jung","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,10]]},"reference":[{"key":"1771_CR1","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","volume":"343","author":"PE Lipsky","year":"2000","unstructured":"Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN (2000) Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N Engl J Med 343:1594\u20131602","journal-title":"N Engl J Med"},{"key":"1771_CR2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/rheumatology\/keh669","volume":"44","author":"A Keat","year":"2005","unstructured":"Keat A, Barkham N, Bhalla A, Gaffney K, Marzo-Ortega H, Paul S, Rogers F, Somerville M, Sturrock R, Wordsworth P (2005) BSR guidelines for prescribing TNF-\u03b1 blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology. Rheumatology (Oxford) 44:939\u2013947","journal-title":"Rheumatology (Oxford)"},{"key":"1771_CR3","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","volume":"345","author":"J Keane","year":"2001","unstructured":"Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun MM (2001) Tuberculosis associated with infliximab, a tumor necrosis factor \u03b1-neutralizing agent. N Engl J Med 345:1098\u20131104","journal-title":"N Engl J Med"},{"key":"1771_CR4","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/art.11137","volume":"48","author":"JJ Gomez-Reino","year":"2003","unstructured":"Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD (2003) Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum 48:2122\u20132127","journal-title":"Arthritis Rheum"},{"key":"1771_CR5","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1002\/art.21137","volume":"52","author":"J Askling","year":"2005","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, Romanus V, Klareskog L, Feltelius N (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52:1986\u20131992","journal-title":"Arthritis Rheum"},{"key":"1771_CR6","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","volume":"52","author":"L Carmona","year":"2005","unstructured":"Carmona L, Gomez-Reino JJ, Rodriguez-Valverde V, Montero D, Pascual-Gomez E, Mola EM, Carreno L, Figueroa M (2005) Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists. Arthritis Rheum 52:1766\u20131772","journal-title":"Arthritis Rheum"},{"issue":"Suppl 1","key":"1771_CR7","doi-asserted-by":"crossref","first-page":"i2","DOI":"10.1136\/ard.2009.123885","volume":"69","author":"DE Furst","year":"2010","unstructured":"Furst DE, Keystone EC, Fleischmann R, Mease P, Breedveld FC, Smolen JS, Kalden JR, Braun J, Bresnihan B, Burmester GR, De Benedetti F, Dorner T, Emery P, Gibofsky A, Kavanaugh A, Kirkham B, Schiff MH, Sieper J, Singer N, Van Riel PL, Weinblatt ME, Weisman MH, Winthrop K (2010) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009. Ann Rheum Dis 69(Suppl 1):i2\u2013i29","journal-title":"Ann Rheum Dis"},{"key":"1771_CR8","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1183\/09031936.00028510","volume":"36","author":"I Solovic","year":"2010","unstructured":"Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Scholvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C (2010) The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement. Eur Respir J 36:1185\u20131206","journal-title":"Eur Respir J"},{"key":"1771_CR9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1136\/ard.62.8.791","volume":"62","author":"X Mariette","year":"2003","unstructured":"Mariette X, Salmon D (2003) French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers. Ann Rheum Dis 62:791","journal-title":"Ann Rheum Dis"},{"key":"1771_CR10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","unstructured":"British Thoracic Society Standards of Care Committee (2005) BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-\u03b1 treatment. Thorax 60:800\u2013805","journal-title":"Thorax"},{"key":"1771_CR11","first-page":"247","volume":"31","author":"JE Fonseca","year":"2006","unstructured":"Fonseca JE, Canhao H, Silva C, Miguel C, Mediavilla MJ, Teixeira A, Castelao W, Nero P, Bernardes M, Bernardo A, Mariz E, Godinho F, Santos MJ, Bogas M, Oliveira M, Saavedra MJ, Barcelos A, Cruz M, Santos RA, Mauricio L, Rodrigues M, Figueiredo G, Quintal A, Patto JV, Malcata A, da Silva JC, Araujo D, Ventura F, Branco J, Queiroz MV (2006) Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience. Acta Reumatol Port 31:247\u2013253","journal-title":"Acta Reumatol Port"},{"key":"1771_CR12","first-page":"6","volume":"101","author":"PM Kavanagh","year":"2008","unstructured":"Kavanagh PM, Gilmartin JJ, O'Donnell J, O'Flanagan D (2008) Tumour necrosis factor-\u03b1 and tuberculosis: guidance from the National TB Advisory Committee. Ir Med J 101:6\u20137","journal-title":"Ir Med J"},{"key":"1771_CR13","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/ard.2004.029041","volume":"64","author":"D Ponce de Leon","year":"2005","unstructured":"Ponce de Leon D, Acevedo-Vasquez E, Sanchez-Torres A, Cucho M, Alfaro J, Perich R, Pastor C, Harrison J, Sanchez-Schwartz C (2005) Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis. Ann Rheum Dis 64:1360\u20131361","journal-title":"Ann Rheum Dis"},{"key":"1771_CR14","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","volume":"149","author":"M Pai","year":"2008","unstructured":"Pai M, Zwerling A, Menzies D (2008) Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 149:177\u2013184","journal-title":"Ann Intern Med"},{"key":"1771_CR15","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10156-009-0686-8","volume":"15","author":"T Mori","year":"2009","unstructured":"Mori T (2009) Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 15:143\u2013155","journal-title":"J Infect Chemother"},{"key":"1771_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1183\/09031936.00115110","volume":"37","author":"R Diel","year":"2011","unstructured":"Diel R, Goletti D, Ferrara G, Bothamley G, Cirillo D, Kampmann B, Lange C, Losi M, Markova R, Migliori GB, Nienhaus A, Ruhwald M, Wagner D, Zellweger JP, Huitric E, Sandgren A, Manissero D (2011) Interferon-\u03b3 release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 37:88\u201399","journal-title":"Eur Respir J"},{"key":"1771_CR17","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.069799","volume":"66","author":"J Sellam","year":"2007","unstructured":"Sellam J, Hamdi H, Roy C, Baron G, Lemann M, Puechal X, Breban M, Berenbaum F, Humbert M, Weldingh K, Salmon D, Ravaud P, Emilie D, Mariette X (2007) Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy. Ann Rheum Dis 66:1610\u20131615","journal-title":"Ann Rheum Dis"},{"key":"1771_CR18","first-page":"776","volume":"35","author":"D Ponce de Leon","year":"2008","unstructured":"Ponce de Leon D, Acevedo-Vasquez E, Alvizuri S, Gutierrez C, Cucho M, Alfaro J, Perich R, Sanchez-Torres A, Pastor C, Sanchez-Schwartz C, Medina M, Gamboa R, Ugarte M (2008) Comparison of an interferon-\u03b3 assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. J Rheumatol 35:776\u2013781","journal-title":"J Rheumatol"},{"key":"1771_CR19","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/ard.2007.070789","volume":"67","author":"G Matulis","year":"2008","unstructured":"Matulis G, Juni P, Villiger PM, Gadola SD (2008) Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon \u03b3 assay. Ann Rheum Dis 67:84\u201390","journal-title":"Ann Rheum Dis"},{"key":"1771_CR20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-0029-1214673","volume":"63","author":"R Diel","year":"2009","unstructured":"Diel R, Hauer B, Loddenkemper R, Manger B, Kruger K (2009) Recommendations for tuberculosis screening before initiation of TNF-\u03b1-inhibitor treatment in rheumatic diseases. Pneumologie 63:329\u2013334","journal-title":"Pneumologie"},{"key":"1771_CR21","first-page":"620","volume":"137","author":"C Beglinger","year":"2007","unstructured":"Beglinger C, Dudler J, Mottet C, Nicod L, Seibold F, Villiger PM, Zellweger JP (2007) Screening for tuberculosis infection before the initiation of an anti-TNF-\u03b1 therapy. Swiss Med Wkly 137:620\u2013622","journal-title":"Swiss Med Wkly"},{"key":"1771_CR22","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.00107608","volume":"33","author":"F Bartalesi","year":"2009","unstructured":"Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D, Tortoli E, Mantella A, Benucci M, Girardi E, Cerinic MM, Bartoloni A (2009) QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 33:586\u2013593","journal-title":"Eur Respir J"},{"key":"1771_CR23","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315\u2013324","journal-title":"Arthritis Rheum"},{"key":"1771_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden van der","year":"1984","unstructured":"van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361\u2013368","journal-title":"Arthritis Rheum"},{"key":"1771_CR25","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3346\/jkms.2007.22.5.779","volume":"22","author":"JW Yun","year":"2007","unstructured":"Yun JW, Lim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Cha HS, Koh EM, Koh WJ (2007) Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea. J Korean Med Sci 22:779\u2013783","journal-title":"J Korean Med Sci"},{"key":"1771_CR26","first-page":"161","volume":"31","author":"GW Comstock","year":"1964","unstructured":"Comstock GW, Edwards LB, Philip RN, Winn WA (1964) A comparison in the United States of America of two tuberculins, Ppd-S and Rt 23. Bull World Health Organ 31:161\u2013170","journal-title":"Bull World Health Organ"},{"issue":"Suppl 1","key":"1771_CR27","first-page":"S1","volume":"15","author":"HL Rieder","year":"2011","unstructured":"Rieder HL, Chadha VK, Nagelkerke NJ, van Leth F, van der Werf MJ (2011) Guidelines for conducting tuberculin skin test surveys in high-prevalence countries. Int J Tuberc Lung Dis 15(Suppl 1):S1\u2013S25","journal-title":"Int J Tuberc Lung Dis"},{"key":"1771_CR28","first-page":"212","volume-title":"Statistical methods for rates and proportions","author":"J Fleiss","year":"1981","unstructured":"Fleiss J (1981) Statistical methods for rates and proportions. Wiley, New York, pp 212\u2013236"},{"key":"1771_CR29","first-page":"413","volume":"24","author":"G Valesini","year":"2006","unstructured":"Valesini G, Montecucco C, Cutolo M (2006) Recommendations for the use of biologic (TNF-\u03b1 blocking) agents in the treatment of rheumatoid arthritis in Italy. Clin Exp Rheumatol 24:413\u2013423","journal-title":"Clin Exp Rheumatol"},{"key":"1771_CR30","first-page":"1427","volume":"13","author":"O Shovman","year":"2009","unstructured":"Shovman O, Anouk M, Vinnitsky N, Arad U, Paran D, Litinsky I, Caspi D, Elkayam O (2009) QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study. Int J Tuberc Lung Dis 13:1427\u20131432","journal-title":"Int J Tuberc Lung Dis"},{"key":"1771_CR31","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3899\/jrheum.081292","volume":"36","author":"B Soborg","year":"2009","unstructured":"Soborg B, Ruhwald M, Hetland ML, Jacobsen S, Andersen AB, Milman N, Thomsen VO, Jensen DV, Koch A, Wohlfahrt J, Ravn P (2009) Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases. J Rheumatol 36:1876\u20131884","journal-title":"J Rheumatol"},{"key":"1771_CR32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","volume":"183","author":"R Diel","year":"2011","unstructured":"Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A (2011) Negative and positive predictive value of a whole-blood interferon-\u03b3 release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med 183:88\u201395","journal-title":"Am J Respir Crit Care Med"},{"key":"1771_CR33","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1465-9921-7-56","volume":"7","author":"I Brock","year":"2006","unstructured":"Brock I, Ruhwald M, Lundgren B, Westh H, Mathiesen LR, Ravn P (2006) Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test. Respir Res 7:56","journal-title":"Respir Res"},{"key":"1771_CR34","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1164\/rccm.200502-196OC","volume":"172","author":"G Ferrara","year":"2005","unstructured":"Ferrara G, Losi M, Meacci M, Meccugni B, Piro R, Roversi P, Bergamini BM, D'Amico R, Marchegiano P, Rumpianesi F, Fabbri LM, Richeldi L (2005) Routine hospital use of a new commercial whole blood interferon-\u03b3 assay for the diagnosis of tuberculosis infection. Am J Respir Crit Care Med 172:631\u2013635","journal-title":"Am J Respir Crit Care Med"},{"key":"1771_CR35","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1183\/09031936.00075008","volume":"33","author":"Y Kobashi","year":"2009","unstructured":"Kobashi Y, Sugiu T, Mouri K, Obase Y, Miyashita N, Oka M (2009) Indeterminate results of QuantiFERON TB-2\u00a0G test performed in routine clinical practice. Eur Respir J 33:812\u2013815","journal-title":"Eur Respir J"},{"key":"1771_CR36","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.3899\/jrheum.090268","volume":"36","author":"N Inanc","year":"2009","unstructured":"Inanc N, Aydin SZ, Karakurt S, Atagunduz P, Yavuz S, Direskeneli H (2009) Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis. J Rheumatol 36:2675\u20132681","journal-title":"J Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1771-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-011-1771-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-011-1771-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T08:51:50Z","timestamp":1559119910000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-011-1771-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,10]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["1771"],"URL":"https:\/\/doi.org\/10.1007\/s10067-011-1771-9","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,10]]}}}